Posts

Showing posts with the label Gene Synthesis Market

Global Gene Synthesis Market: Trends, Innovations, and Growth Opportunities 2023-2030

  The global  gene synthesis market  size is expected to reach USD 5.78 billion by 2030, registering a CAGR of 16.1% from 2023 to 2030 according to a new report by Grand View Research, Inc. Development of the market is due  to the growing investment in the synthetic biology field, favorable government regulations, and technological advancements in the gene synthesis market. In January 2022, synthetic DNA manufacturer Twist Bioscience announced plans of developing EDS technology at the J.P. Morgan Health Care Conference. The company established an enzymatic DNA synthesis technology that is novel, low-cost, scarless, and scalable.   The introduction of novel DNA synthesis platforms with technologically advanced specifications that address the increased demand of researchers is also contributing to the overall growth. For instance, in June 2021, DNA Script introduced the SYNTAX System, which is the nucleic acid printer based on EDS technology. Similarly, in Decembe...

Gene Synthesis Market size is expected to reach USD 5.58 billion by 2028

  Gene Synthesis Industry Overview The global gene synthesis market size was valued at USD 1.47 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 18.1% from 2021 to 2028. The supportive government policies associated with synthetic biology are key driving factors of the market. With the growing demand for synthetic biology, investors have shifted their focus on this field over the past few years. In 2020, approximately, USD 8 billion were invested in the synthetic biology field by public and private financing. The ongoing COVID-19 pandemic has been advantageous for the market, in terms of new growth opportunities. Scientific communities are exploring untapped avenues in the space, thereby contributing to revenue growth. For instance, researchers at the National Institute of Standards and Technology (NIST) have produced synthetic gene fragments from the COVID-19 virus to help diagnostic developers develop more reliable and accurate diagno...